產(chǎn)品詳情
簡單介紹：
Anti-LCMV RNA-directed RNA polymerase L抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-LCMV RNA-directed RNA polymerase L抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-LCMV RNA-directed RNA polymerase L
Cat. Number:
Anti-LCMV RNA-directed RNA polymerase L抗體KL-2836R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Lymphocytic choriomeningitis virus (LCMV), the first member of the arenavirus family to be isolated, is the causative agent of a zoonosis acquired from chronically viremic mice or hamsters. LCMV primarily infects wild mice and it is Anti-LCMV RNA-directed RNA polymerase L抗體estimated that 5% of all wild mice carry LCMV. Mice can asymptomatically carry and shed the virus in saliva, urine and faeces. People and other animals become infected through contact with these secretions or by inhalation of dried particles from them. The clinical spectrum of acquired human LCMV infection ranges from inapparent and asymptomatic to, in rare instances, severely symptomatic, systemic, and fatal central nervous system (CNS) disease. Intrauterine LCMV infection has resulted in fetal or neonatal death, as well as hydrocephalus and chorioretinitis in infants.
Also known as:
Lymphocytic choriomeningitis virus; Anti-LCMV RNA-directed RNA polymerase L抗體L_LYCVA; RNA-directed RNA polymerase L; L; Protein L; Large structural protein; Replicase; Transcriptase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: LCMV.
●
Immunogen: KLH Anti-LCMV RNA-directed RNA polymerase L抗體conjugated synthetic peptide derived from LCMV RNA-directed RNA polymerase L.
●
Predicted Molecular Weight: 243kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-LCMV RNA-directed RNA polymerase L抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-LCMV RNA-directed RNA polymerase L抗體
Optimal working dilutions must be determined by the end user.
